Zepto Life Technology Selected to Present Poster at the RESI Boston 2019 Innovation Challenge on September 11th

Zepto Life Technology Selected to Present Poster at the RESI Boston 2019 Innovation Challenge on September 11th
August 27, 2019 at 7:00 AM EDT

ST. PAUL, Min.–August 27, 2019—Zepto Life Technology announced today that an overview of the company’s business strategy and development-stage programs will be presented at the RESI Boston 2019 Innovation Challenge being held at the Westin Copley Place hotel in Boston. The company’s poster presentation will be available on Wednesday, September 11, 2019, from 7:00 AM EDT until 5:00 PM EDT.
For more information about the RESI Boston 2019 Innovation Challenge, please refer to the conference website at https://www.resiconference.com/innovation-challenge/.
About Zepto Life Technology, LLC
Zepto Life Technology is a pioneering biotechnology company devoted to improving people’s quality of life through the development of portable instruments and assays for applications including disease diagnostics, water quality monitoring, food safety, and more. Zepto combines leading-edge magnetic sensor technology with conventional assay knowledge to provide advanced solutions to the most difficult challenges faced globally.
Forward-looking statement — This press release may contain forward-looking statements regarding future events and the future performance of Zepto Life Technology that involve risks and uncertainties that could cause actual results to differ materially. These statements are based on management’s current beliefs and expectations. These statements include, but are not limited to, statements that relate to Zepto’s business and its future, including certain company milestones, and any statements that relate to the intent, belief, plans or expectations of Zepto or its management, or that are not a statement of historical fact. Risks that could cause actual results to differ include the possibility that Zepto’s existing and new product candidates may not prove safe or effective, the possibility that our applications to the FDA and other regulatory agencies may not receive approval in a timely manner or at all, the possibility that our existing and new product candidates, if approved, may not be more effective, safer or more cost efficient than competing products, our dependence on third parties for clinical trials, manufacturing, distribution and quality control, and other risks. The company does not plan to update any such forward-looking statements and expressly disclaims any duty to update the information contained in this press release except as required by law.
ZEPTO LIFE TECHNOLOGY, LLC® is a registered trademark of Zepto Life Technology, LLC and the Zepto logos are trademarks owned by Zepto Life Technologies, LLC. .Any other trademarks are the property of their respective owners.
© 2019 Zepto Life Technology, LLC. All Rights Reserved
Contact:
investor@zeptolife.com
(651)-641-3615